When Things Go Wrong Ep12:The Spec Symphony: Determining Identity, Purity, Strength, and Composition

This month’s webinar featured David Vaillencourt, Founder & CEO of The GMP Collective, along with Pamela Epstein, Chief Legal & Regulatory Officer at Terpene Belt, Inc., and Dr. Nandu Sarma, Director of Dietary Supplements and Herbal Medicines at the US Pharmacopeia. We discussed what specifications mean in regards to product safety and quality and focused heavily on standards.
Links Discussed in the Webinar
• USP provides valuable resources here www.usp.org/di...
• USP 〈1568〉 Quality Considerations for Cannabis and Cannabis-Derived Products for Clinical Research (You need to create a free log in to access) login.usp.org/...
• Compendial notice www.uspnf.com/...
• Summary of ASTM and USP’s Global Workshop on Cannabis Quality Part One including all slide decks are now available here www.usp.org/di...
• Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes by Nandu Sarma, et. al., 2020, Journal of Natural Products pubs.acs.org/d...
• Isolation and Characterization of Impurities in Commercially Marketed Δ8-THC Products by Mohamed M. Radwan, et. al., 2023, Journal of Natural Products pubs.acs.org/d...
• ‘Cannabis’ Ontologoes I: Conceptual Issues with Cannabis and Cannabinoids Terminology by Kenzi Riboulet-Zemouli, 2020, Drug Science journals.sagep...
• Become an ASTM International member and get involved at ASTM's D37 on Cannabis www.astmcannab...
• ASTM WK84589 New Specification for What is an Intoxicating Cannabinoid www.astm.org/w...